AgomAb Therapeutics Financials - Benzinga

SPY766.77+0.34%QQQ742.23+0.58%BTC/USD84,003.00+0.45%DIA511.13−0.34%GLD380.76−0.56%TLT77.57−0.85%

AgomAb Therapeutics NV

AGMBNASDAQ

Trade with Public

Trade with Public

$11.29

0.767.22%

Last update: Sep 30, 1:15 PM

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Compare Stock Report

AgomAb Therapeutics Financials

AgomAb Therapeutics (AGMB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
AgomAb Therapeutics H1 EPS $(0.93)

AgomAb Therapeutics (NASDAQ:AGMB) reported quarterly losses of $(0.93) per share.

Benzinga Newsdesk